跳至主要内容
临床试验/EUCTR2004-004612-23-IT
EUCTR2004-004612-23-IT进行中(未招募)不适用

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort Designed, Escalating Dose Study to Assess the Tolerability, Safety and Maximal Tolerated Dose MTD of Ladostigil in Patients with Mild to Moderate Alzheimer s Disease

TEVA0 个研究点目标入组 72 人开始时间: 2006年12月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
TEVA

相似试验

进行中(未招募)
1 期
Efficacy, Safety, and Durability of Response of BMS-986165 versus Placebo and Active Comparator in Subjects with PsoriasisModerate-to-Severe Plaque PsoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858
EUCTR2018-001925-24-CZBristol-Myers Squibb International Corporation1,000
进行中(未招募)
不适用
A Multi-Center, Randomized, Double-Blind, Placebo-controlled Study of Adalimumab in Japanese Subjects with Moderately to Severely Active Ulcerative Colitis
EUCTR2014-004559-29-Outside-EU/EEAAbbVie Inc.274
进行中(未招募)
不适用
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyComparing SYR-322 Alone and Combination SYR-322 with Pioglitazone versus Placebo on Postprandial Lipids in Subjects with Type 2 Diabetes - Post-Prandial
EUCTR2007-000486-38-NLTakeda Global Research & Development Centre (Europe) Ltd.,71
进行中(未招募)
1 期
Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patientsCharcot Marie Tooth Type 1AMedDRA version: 20.0Level: LLTClassification code 10008414Term: Charcot-Marie-Tooth diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2020-004805-30-DKPharnext SCA387
进行中(未招募)
1 期
Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patientsCharcot Marie Tooth Type 1AMedDRA version: 20.0Level: LLTClassification code 10008414Term: Charcot-Marie-Tooth diseaseSystem Organ Class: 100000004850
EUCTR2020-004805-30-ITPharnext SA350